Screener
Tectonic Therapeutics TECX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Tectonic Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
FAQ
- What is Tectonic Therapeutics's return on equity?
- Tectonic Therapeutics (TECX) reported return on equity of -31.4% in Q1 2026.
- What is the long-term trend for Tectonic Therapeutics's return on equity?
- Over 2 years (2020 to 2025), Tectonic Therapeutics's return on equity has grown at a -16.6% compound annual growth rate (CAGR), from -54.4% to -37.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Tectonic Therapeutics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude